跳至主要内容
临床试验/CTRI/2025/07/091233
CTRI/2025/07/091233尚未招募2/3 期

Randomized controlled clinical trial to compare the efficacy of oral administration of tekrajras syrup with levosalbutamol syrup in kaphaj kasa in children

TILAK AYURVED MAHAVIDYALAYA1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年7月31日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
70
试验地点
1
主要终点
Decrease In Kasa

研究概览

简要总结

The study will be intervened by the treatment of Tekrajras syrup and Levosalbutamol syrup to group A and group B respectively. The efficacy of the therapy will be assessed on the basis of subjective and objective criteria for statistical analysis. Scoring will be designed according to the severity of symptoms. The subjective and objective gradation of symptoms will be done as follows and the intensity of each symptom will be calculated before treatment, after treatment and after follow up. The effect of treatment result will be assessed in regards to clinical signs and symptoms on the basis of grading and scoring system. The signs and symptoms will be assessed by adopting the suitable scoring method.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
4.00 Year(s) 至 10.00 Year(s)(—)
性别
All

入选标准

  • Participant having classical signs and symptoms like Aruchi, Shirshula, Pinasa, kaphaj kasa etc.
  • Age group 4 to 10 years
  • Both male and female children will be included
  • Participant suffering from kaphaj kasa less than 7 days.

排除标准

  • Kasa Other Than Kaphaj Kasa
  • Participant Having Respiratory Distress Syndrome Like Tachypnea,Nasal Flaring,Retraction Etc
  • Kasa More Than 7 Days And Other Disease Of Respiratoey Tract Like Lrti,Copd,Asthma,Emphysema And Febrile Condition Etc.

结局指标

主要结局

Decrease In Kasa

时间窗: 3 Days

次要结局

  • Decrease In Kasa And Kapha Production,Aruchi,Shirshula,Pratishyaya(7 Days)

研究者

申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Shivaji Sarjerao Ghongade

Tilak Ayurved Mahavidyalaya,Pune

研究点 (1)

Loading locations...

相似试验